CDC Releases Hanford Thyroid Disease Study Final Report

CDC Releases Hanford Thyroid Disease Study Final Report

ArticlePress release
Health & Wellness
Diseases & Conditions
Contributed byLester Fahrner, MDMar 16, 2020

CDC Releases Hanford Thyroid Disease Study Final Report

Data Show Risks of Thyroid Disease About the Same Regardless of Radiation Dose from Hanford

Findings announced from the Hanford Thyroid Disease Study (HTDS) Final Report show that the risks of thyroid disease in study participants were about the same regardless of the radiation dose they received from radioactive iodine-131 from the Hanford Nuclear Weapons Production Facility in Washington State between 1944 and 1957. While thyroid disease was found, researchers determined that rates of the disease in the study participants were about the same as rates in other populations.

The Centers for Disease Control and Prevention (CDC) and the Fred Hutchinson Cancer Research Center released the findings of the 13-year study at a community meeting in Richland, Washington.

"We used the best scientific methods available, and we did not find an increased risk of thyroid disease in study participants from exposure to Hanford's iodine-131," said Paul Garbe, D.V.M, epidemiologist and CDC's scientific advisor for the study. "If there is an increased risk of thyroid disease, it is too small to observe."

The HTDS research team studied all types of thyroid diseases and examined how the rates varied in relation to participants' estimated radiation doses from Hanford's iodine-131.

"On the basis of a study population of 3,440 people, we found that people with higher doses of radiation had about the same amount of thyroid disease as people with lower doses," said Scott Davis, PhD, Fred Hutchinson's principal investigator for the HTDS. "We analyzed the data a number of ways, and the results were the same."

The research team also found that the rates of thyroid disease in the people who participated in the HTDS were generally consistent with the rates of disease in other populations in the United States, based on a review of published scientific literature conducted after the release of the HTDS Draft Report in 1999.

(more)

"Thyroid disease is fairly common in other populations across the country, especially among older people and women," Garbe said. "However, we understand the concern that people in the Hanford region have about thyroid disease, given their exposure to iodine-131, and we want to provide as much detail as possible about our findings and what they mean."

The HTDS focused on a group of people who were young children when they were exposed to iodine-131 from Hanford between 1944 and 1957. Iodine-131 accounted for most of the radiation dose to the people exposed to Hanford's radiation. Scientists believe that young children receive a higher dose to the thyroid gland than adolescents and adults for the same level of exposure and that the thyroid gland in young children may be more sensitive to the effects of radiation.


The HTDS study population represents a sampling of people born between 1940 and 1946 to mothers who lived in seven counties in Washington State: Benton, Franklin, Adams, Walla Walla, Okanogan, Ferry, and Stevens. Each participant underwent a complete evaluation for thyroid disease as part of the study. Detailed information about what participants ate and where they lived were also collected as a part of the study.

Study participants had a wide range of possible doses to the thyroid gland, from very high to very low doses. This range enabled researchers to compare groups of people who have similar characteristics (such as birth, diet and lifestyle) but different levels of exposure. This approach of studying a single population comprising individuals with different levels of exposure has been used extensively in assessing the effects of radiation exposure in human populations.


A committee of the National Academy of Sciences evaluated the HTDS at three stages in the study. Other independent scientists and members of the public provided input to the HTDS research throughout the study.


Congress mandated the HTDS in 1988 after the U.S. Department of Energy made public documents revealing that large quantities of radioactive materials were released from the Hanford Nuclear Weapons Plant in the 1940s and 1950s, especially in 1945.

CDC protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations.

###

Note: All HHS press releases, fact sheets and other press materials are available at www.hhs.gov/news.

Was this article helpful

On the Article

Lester Fahrner, MD picture
Approved by

Lester Fahrner, MD

Chief Medical Officer, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!